n-hydroxysulfosuccinimide has been researched along with Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CC; Chang, YC; Chen, HW; Chen, JS; Chen, PH; Cheng, TM; Chou, CC; Chou, FH; Chu, HL; Ho, LP; Hsu, MH; Li, MP; Tsai, LY; Tseng, SH | 1 |
Li, J; Li, X; Li, Y; Liu, W; Mu, H; Sun, K; Wang, A; Wang, M; Wu, Z; Zhang, X | 1 |
2 other study(ies) available for n-hydroxysulfosuccinimide and Neoplasms
Article | Year |
---|---|
Development of a growth-hormone-conjugated nanodiamond complex for cancer therapy.
Topics: Antineoplastic Agents; Biocompatible Materials; Cell Death; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Green Fluorescent Proteins; Growth Hormone; Humans; Lasers; Molecular Structure; Nanodiamonds; Neoplasms; Particle Size; Receptors, Somatotropin; Structure-Activity Relationship; Succinimides; Surface Properties | 2014 |
Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration.
Topics: Animals; Cell Line, Tumor; Cell Survival; Cell-Penetrating Peptides; Cells, Cultured; Dendrimers; Female; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Maleimides; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Polyethylene Glycols; Succinimides; tat Gene Products, Human Immunodeficiency Virus | 2016 |